You Position: Home > Paper
Back to the preclinical medicine:Evaluation of the safety of insulin detemir
( views:288, downloads:383 )
- Author:
- No author available
- Journal Title:
- Chinese Journal of Diabetes
- Issue:
- 8
- DOI:
- 10.3969/j.issn.1006-6187.2012.08.023
- Key Word:
- 地特胰岛素;胰岛素类似物;基础胰岛素;安全性;变异性;低血糖;体重
Abstract： 地特胰岛素作为长效胰岛素类似物,在有效降低空腹血糖,促进HbA1c达标的同时,还具有血糖变异性小、低血糖风险低、体重增加少,以及分子安全性好等优势.越来越多的临床研究证实,地特胰岛素在儿童、青少年、妊娠妇女,以及老年人等特殊糖尿病人群中的应用也是有效和安全的.地特胰岛素为糖尿病患者进行起始基础胰岛素治疗时提供了理想的选择.
- [1]Fajardo-Montanana C,Hernandez-Herrero C,Rivas-Fernandez M.Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.[J].2008,25(8).
- [2]Heise T,Pieber TR.Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies.[J].2007,9(5).
- [3]Gupta GK,Gupta VK,Shukla.Investigations on cellular interaction of polyelectrolyte based nano-walled reservoir using MCF-7 cell lines: a novel chemotherapeutic approach.[J].2009,61(12).
- [4]Marchionni N,Mannucci E,Monami M.Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.[J].2008,81(2).
- [5]Dornhorst A,Hansen JB,Luddeke HJ,etc.Insulin detemir improves glycaemic control without weight gain in insulin-naive patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study.[J].2008,62(4).
- [6]Dizdarer C,Pirgon O,Atabek ME,etc.Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE observational study.[J].2009,10(6).
- [7].Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics[J].2010.
- [8]Walte K,Von Schuetz W,Lupke K,etc.Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes.[J].2003,26(11).
- [9]Home P,Kurtzhals P.Insulin detemir: from concept to clinical experience.[J].2006,7(3).
- [10]Philis-Tsimikas A.An update on the use of insulin detemir, with a focus on type 2 diabetes (drug evaluation update).[J].2008,9(12).
- [11]Kerlan,V.,Vergés,B.,Tawil,C.,etc.Insulin initiation in elderly patients with type 2 diabetes in France: A subpopulation of the LIGHT study[J].2012,28(4).
- [12]Katarina, Raslova.An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog.[J].2010,6.
- [13]Charpentier G,Thorsteinsson B,Philis-Tsimikas A,etc.Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.[J].2006,28(10).
- [14]McCance,D.R.,Damm,P.,Mathiesen,E.R.,etc.Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes[J].2012,35(10).
- [15]Mathew, John.Basal insulin analogues--a review of recent data on efficacy and safety.[J].2011,59 Suppl.